Publications by authors named "E L Wrenn"

Purpose: Despite limited genetic and histologic heterogeneity, Ewing sarcoma (EwS) tumor cells are transcriptionally heterogeneous and display varying degrees of mesenchymal lineage specification in vitro. In this study, we investigated if and how transcriptional heterogeneity of EwS cells contributes to heterogeneity of tumor phenotypes in vivo.

Experimental Design: Single-cell proteogenomic-sequencing of EwS cell lines was performed and integrated with patient tumor transcriptomic data.

View Article and Find Full Text PDF

Tumor heterogeneity is a major driver of cancer progression. In epithelial-derived malignancies, carcinoma-associated fibroblasts (CAFs) contribute to tumor heterogeneity by depositing extracellular matrix (ECM) proteins that dynamically remodel the tumor microenvironment (TME). Ewing sarcomas (EwS) are histologically monomorphous, mesenchyme-derived tumors that are devoid of CAFs.

View Article and Find Full Text PDF

Accumulating evidence shows that despite clonal origins tumors eventually become complex communities comprised of phenotypically distinct cell subpopulations. This heterogeneity arises from both tumor cell intrinsic programs and signals from spatially and temporally dynamic microenvironments. While pediatric cancers usually lack the mutational burden of adult cancers, they still exhibit high levels of cellular heterogeneity that are largely mediated by epigenetic mechanisms.

View Article and Find Full Text PDF
Article Synopsis
  • The study explores how HOXD13 affects the transcriptional activity of EWS::FLI1, a key player in Ewing sarcoma progression.
  • By utilizing various experimental techniques, the authors identify the interaction between HOXD13 and EWS::FLI1, discovering that HOXD13 can both activate and inhibit genes influenced by EWS::FLI1.
  • Ultimately, the findings suggest that Ewing sarcoma cells function on a mesenchymal transcriptional continuum, influenced by the balance of activities between HOXD13 and EWS::FLI1.
View Article and Find Full Text PDF

The metastatic process is arduous. Cancer cells must escape the confines of the primary tumor, make their way into and travel through the circulation, then survive and proliferate in unfavorable microenvironments. A key question is how cancer cells overcome these multiple barriers to orchestrate distant organ colonization.

View Article and Find Full Text PDF